Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-21-013698

Chief Financial Officer sold 2,500 shares at $198.47 ($496,175)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2021-04-12 Sale −2,500 $198.47 $496,175 94,922 D: show line 1 in the form
Open-market sales · 2,500 sh · avg $198.47 · $496,175
Loading xslF345X03/form4.xml…